Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 7/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | INSR | P06213 | 1/20 | 0.44 |
| ▸ | IGF1R | P08069 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7065103 | 1.00 | CA1 (0.46) | CA1CA2CYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL31390245 | 1.00 | CA1 (0.46) | CA1CA2CYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL23264548 | 0.97 | CYP2A6 (0.44) | CA1CA2CYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL17930261 | 0.97 | CYP2A6 (0.44) | CA1CA2CYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL23264365 | 0.93 | ALDH1A1 (0.50) | CA1CA2CYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL23264547 | 0.93 | ALDH1A1 (0.50) | CA1CA2CYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL23264551 | 0.93 | ALDH1A1 (0.50) | CA1CA2CYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL2538296 | 0.93 | ALDH1A1 (0.50) | CA1CA2CYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL13020773 | 0.93 | ALDH1A1 (0.50) | CA1CA2CYP2A6CYP1A2ALDH1A1 | |
| SCHEMBL13720810 | 0.93 | ALDH1A1 (0.50) | CA1CA2CYP2A6CYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230375936-A1 | COMPOSITION FOR DEVELOPING AND METHOD OF FORMING PATTERN USING THE SAME | Lee, Geun Su (KR) | 2023-11-23 | — | — | US | disclosed |
| US-8829783-B2 | Trinaphthyl monoamine or derivative thereof, organic electroluminescent device using the same, and organic electroluminescent material-containing solution | IDEMITSU KOSAN CO., LTD. (JP) | 2014-09-09 | — | — | US | disclosed |
| US-8829783-B2 | Trinaphthyl monoamine or derivative thereof, organic electroluminescent device using the same, and organic electroluminescent material-containing solution | IDEMITSU KOSAN CO., LTD. (JP) | 2014-09-09 | — | — | US | disclosed |
| WO-2011041529-A3 | TRI-2-NAPHTHYLAMINES | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-08-18 | — | — | WO | disclosed |
| WO-2011041529-A2 | TRI-2-NAPHTHYLAMINES | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011041529-A2 | TRI-2-NAPHTHYLAMINES | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011041529-A2 | TRI-2-NAPHTHYLAMINES | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-04-07 | — | — | WO | disclosed |
| US-7914909-B2 | Organic electroluminescent device | CANON KABUSHIKI KAISHA (JP) | 2011-03-29 | — | — | US | disclosed |
| US-20100156285-A1 | TRINAPHTHYL MONOAMINE OR DERIVATIVE THEREOF, ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME, AND ORGANIC ELECTROLUMINESCENT MATERIAL-CONTAINING SOLUTION | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100156285-A1 | TRINAPHTHYL MONOAMINE OR DERIVATIVE THEREOF, ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME, AND ORGANIC ELECTROLUMINESCENT MATERIAL-CONTAINING SOLUTION | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-7423168-B2 | Reacting allyl starting compound with oxygen nucleophilic agent in presence of transition metal catalyst and monodentate phosphite | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-09-09 | — | — | US | disclosed |
| US-7241857-B2 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-07-10 | — | — | US | disclosed |
| US-20070155636-A1 | Lubricating oil additive and lubricating oil composition containing the same | ADEKA CORPORATION (JP) | 2007-07-05 | — | — | US | disclosed |
| US-7173157-B2 | Method for producing an allyl compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-02-06 | — | — | US | disclosed |
| EP-1717298-A1 | LUBRICATING OIL ADDITIVE AND LUBRICATING OIL COMPOSITION CONTAINING SAME | Adeka Corporation (JP) | 2006-11-02 | — | — | EP | disclosed |
| US-7119222-B2 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-10-10 | — | — | US | disclosed |
| US-20060106181-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-05-18 | — | — | US | disclosed |
| US-20050075518-A1 | Method for producing allyl compound, and allyl compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2005-04-07 | — | — | US | disclosed |
| US-20040147757-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-07-29 | — | — | US | disclosed |
| US-20040092777-A1 | Method for producing allyl compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106181-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | AGPAT5, TST, AGPAT2 | CA1 282/4885CA2 756/4885CYP2A6 177/4885 |
| US-20040147757-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | AGPAT5, TST, AGPAT2 | CA1 282/4885CA2 756/4885CYP2A6 177/4885 |
| US-20100156285-A1 | TRINAPHTHYL MONOAMINE OR DERIVATIVE THEREOF, ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME, AND ORGANIC ELECTROLUMINESCENT MATERIAL-CONTAINING SOLUTION | MAOA, COMT, MAOB | CA1 2557/4885CA2 4756/4885CYP2A6 2742/4885 |
| US-20040092777-A1 | Method for producing allyl compound | CCNT1, APEX1, REV1 | CA1 198/4885CA2 788/4885CYP2A6 1590/4885 |
| US-20050075518-A1 | Method for producing allyl compound, and allyl compound produced thereby | CCNT1, AOC3, ATL3 | CA1 1413/4885CA2 2279/4885CYP2A6 143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.